department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Palynziq · pharmadog

pharmadog
drugs
Palynziq

drug

patient view →

pegvaliase

Marketedupdated 2mo ago

by $BMRN BIOMARIN PHARMACEUTICAL INC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Palynziq

generic

pegvaliase [INN]

indication

Hyperphenylalaninemia

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 57m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 1

tagApproval32 co-mentions · 8 sources

Trials studying pegvaliase

phase4Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziqactive not recruitingn=9
—A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)recruitingn=450
—A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)recruitingn=200
—A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeedingrecruitingn=50
phase4Immune Modulation During Palynziq® Treatment in Adults (IMPALA)not yet recruitingn=12
—Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)recruitingn=45
—Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKUcompletedn=6
phase3Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuriaactive not recruitingn=55

more trials →